A new Real-Time-RT-PCR for quantitation of human endogenous retroviruses type K (HERV-K) RNA load in plasma samples: Increased HERV-K RNA titers in HIV-1 patients with HAART non-suppressive regimens

Journal of Virological Methods

Volumn 136, Issue 1-2, 2006, Pages 51-57

  Contreras Galindo, Rafael ^a   González, Marta ^a   Almodovar Camacho, Sharilyn ^a   González Ramírez, Sandra ^a   Lorenzo, Eric ^a   Yamamura, Yasuhiro ^a  

^a PONCE SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

HERV K; HERV K viral load; HIV 1; Real Time RT PCR; Sybr Green

Indexed keywords

ANTIRETROVIRUS AGENT; REAGENT; VIRUS RNA;

ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN ENDOGENOUS RETROVIRUS TYPE K; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PERFORMANCE; PLASMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; RETROVIRUS; RETROVIRUS INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA SEQUENCE; SEROLOGY; TECHNOLOGY; TITRIMETRY; VARIANCE; VIRUS DETECTION; VIRUS PARTICLE; VIRUS TYPING;

ANALYSIS OF VARIANCE; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BASE SEQUENCE; CLONING, MOLECULAR; ENDOGENOUS RETROVIRUSES; FLUORESCENCE; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; ORGANIC CHEMICALS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; STAINING AND LABELING; VIRAL LOAD;

HEPATITIS C VIRUS; HUMAN ENDOGENOUS RETROVIRUSES; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33746159892     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2006.03.029     Document Type: Article

References (32)

1. Bannert N., and Kurth R. Retroelements and the human genome: new perspectives on an old relation. Proc. Natl. Acad. Sci. U.S.A. 101 (2002) 14572-14579
2. Bieda K., Hoffmann A., and Boller K. Phenotypic heterogeneity of human endogenous retrovirus particles produced by teratocarcinoma cell lines. J. Gen. Virol. 3 (2001) 591-596
3. Boller K., Konig H., Sauter M., Mueller-Lantzsch N., Lower R., Lower J., and Kurth R. Evidence that HERV-K is the endogenous retrovirus sequence that codes for the human teratocarcinoma-derived retrovirus HTDV. Virology 1 (1993) 349-353
4. Clementi M., Menzo S., Bagnarelli P., Valenza S., Paolucci R., Sampaolesi A., Manzin C., and Varaldo P.E. Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection. Clin. Microbiol. Rev. 9 (1996) 135-147
5. Coste J., Montes B., Reynes J., Peeters M., Vendrell J.P., Delaporte E., and Segondy M. Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma. J. Med. Virol. 50 (1996) 293-302
6. Deeks S., Barbour J.D., Grant R.M., and Martin J.N. Duration and predictors of CD4 T-cell gain in patients who continue combination therapy despite detectable plasma viremia. AIDS 16 (2002) 201-207
7. Delobel P., Sandres-Saune K., Cazabat M., L'Faqihi F.E., Aquilina C., Obadia M., Pasquier C., Marchou B., Massip P., and Izopet J. Persistence of distinct HIV-1 populations in blood monocytes and I and memory CD4 T cells during prolonged suppressive HAART. AIDS 19 (2005) 1739-1750
8. Depil S., Roche C., Dussart P., and Prin L. Expression of a human endogenous retrovirus, HERV-K, in the blood cells of leukaemia patients. Leukaemia 16 (2002) 254-259
9. Gibellini D., Vitone F., Gori E., La Placa M., and Re M.C. Quantitative detection of human immunodeficiency virus type 1 (HIV-1) viral load by SYBR green real-time RT-PCR technique in HIV-1 seropositive patients. J. Virol. Methods 115 (2004) 183-189
10. Hughes J., and Coffin J. Human endogenous retrovirus K solo-LTR formation and insertional polymorphisms: implications for human and viral evolution. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 1672-1688
11. Johnston J., Silva C., Holden J., Warren K., Clark A., and Power C. Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases. Ann. Neurol. 50 (2001) 434-442
12. Lecossier D., Bouchonnet F., Schneider P., Clavel F., and Hance A.J. Centre de Recherche Integre sur le VIH Bichat-Claude Bernard. Discordant increases in CD4+ T cells in human immunodeficiency virus-infected patients experiencing virologic treatment failure: role of changes in thymic output and T cell death. J. Infect. Dis. 183 (2001) 1009-1016
13. Lower R., Lower J., and Kurth R. The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 5177-5184
14. Mack M., Bender K., and Schneider P.M. Detection of retroviral antisense transcripts and promoter activity of the HERV-K(C4) insertion in the MHC class III region. Immunogenetics 56 (2004) 321-332
15. McClure M.A., Johnson M.S., Feng D.F., and Doolittle R.F. Sequence comparisons of retroviral proteins: relative rates of change and general phylogeny. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 2469-2473
16. Medstrand P., and Blomberg J. Characterization of novel reverse transcriptase encoding human endogenous retroviral sequences similar to type A and type B retroviruses: differential transcription in normal human tissues. J. Virol. 67 (1993) 6778-6787
17. Mellors J.W., Rinaldo Jr. C.R., Gupta P., White R.M., Todd J.A., and Kingsley L.A. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272 (1996) 1167-1170 (Erratum in Science 1997, Jan 275, 14)
18. Moyes D., Martin A., Sawcer S., Temperton N., Worthington J., Griffiths D., and Venables P. The distribution of the endogenous retroviruses HERV-K113 and HERV-K115 in health and disease. Genomics 86 (2005) 337-341
19. Nelson P., Carnegie P., Martin J., Davari E., Hooley P., Roden D., Rowland-Jones S., Warren P., Astley J., and Murray P. Demystified human endogenous retroviruses. Mol. Pathol. 56 (2003) 11-18
20. Noe A., Plum J., and Verhofstede C. The latent HIV-1 reservoir in patients undergoing HAART: an archive of pre-HAART drug resistance. J. Antimicrob. Chemother. 55 (2005) 410-412
21. Orenstein J. Human endogenous retroviral expression by leukocytes. Ultrastruct. Pathol. 24 (2000) 123-124
22. Piketty C., Weiss L., Thomas F., Mohamed A.S., Belec L., and Kazatchkine M.D. Long-term outcome of HIV-infected patients with discordant immunologic and virologic responses to a protease inhibitor-containing regimen. J. Infect. Dis. 183 (2001) 1328-1335
23. Pitrak D.L., Bolanos J., Hershow R., and Novak R.M. Discordant CD4 T lymphocyte responses to antiretroviral therapy for HIV infection are associated with ex-vivo rates of apoptosis. AIDS 15 (2001) 1317-1319
24. Simpson G., Patience C., Lower R., Tonjes R., Moore H., Weiss R., and Boyd M. Endogenous D-type (HERV-K) related sequences are packaged into retroviral particles in the placenta and possess open reading frames for reverse transcriptase. Virology 222 (1996) 451-456
25. Stevens R., Baltch A., Smith R., McCreedy B., Michelsen P., Bopp L., and Urnovitz H. Antibody to human endogenous retrovirus peptide in urine of human immunodeficiency virus type 1-positive patients. Clin. Diagn. Lab. Immunol. 6 (1999) 783-786
26. Sufka S.A., Ferrari G., Gryszowka V.E., Wrin T., Fiscus S.A., Tomaras G.D., Staats H.F., Patel D.D., Sempowski G.D., Hellmann N.S., Weinhold K.J., and Hicks C.B. Prolonged CD4+ cell/virus load discordance during treatment with protease inhibitor-based highly active antiretroviral therapy: immune response and viral control. J. Infect. Dis. 187 (2003) 1027-1037
27. Turner G., Barbulescu M., Su M., Jensen-Seaman M., Kidd K., and Lenz J. Insertional polymorphisms of full-length endogenous retroviruses in humans. Curr. Biol. 11 (2001) 1531-1535
28. Varga A., and James D. Real-time RT-PCR and SYBR Green I melting curve analysis for the identification of Plum pox virus strains C, EA, and W: Effect of amplicon size, melt rate, and dye translocation. J. Virol. Methods 132 (2005) 146-153
29. Verhofstede C., Noe A., Demecheleer E., De Cabooter N., Van Wanzeele F., Van Der Gucht B., Vogelaers D., and Plum J. Drug-resistant variants that evolve during non-suppressive therapy persist in HIV-1-infected peripheral blood mononuclear cells after long-term highly active antiretroviral therapy. J. Acquir. Immun. Defic. Syndr. 15 (2004) 473-483
30. Vogetseder W., Dumfahrt A., Mayersbach P., Schonitzer D., and Dierich M. Antibodies in human sera recognizing a recombinant outer membrane protein encoded by the envelope gene of the human endogenous retrovirus K. AIDS Res. Hum. Retroviruses 9 (1993) 687-694
31. Wang-Johanning F., Frost A., Jian B., Epp L., Lu D., and Johanning G. Quantitation of HERV-K env gene expression and splicing in human breast cancer. Oncogene 22 (2003) 1528-1535
32. Wood E., Hogg R.S., Yip B., Tyndall M.W., Sherlock C.H., Harrigan R.P., O'Shaughnessy M.V., and Montaner J.S. "Discordant" increases in CD4 cell count relative to plasma viral load in a closely followed cohort of patients initiating antiretroviral therapy. J. Acquir. Immun. Defic. Syndr. 30 (2002) 159-166